RVU120 in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome
Clinical trial NCT04021368 · UNKNOWN
Trial details
- NCT number
- NCT04021368
- Sponsor
- Ryvu Therapeutics SA
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-04
- Primary completion
- 2024-12-30
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.